Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_assertion type Assertion NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_head.
- NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_assertion description "[WNT10B mRNA was relatively highly expressed in TE3, TE6, TE10, TE11 (esophageal cancer), Hs700T (pancreatic cancer), SKG-IIIa, HeLa S3 (cervical cancer), and T-47D (breast cancer).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_provenance.
- NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_assertion evidence source_evidence_literature NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_provenance.
- NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_assertion SIO_000772 12239602 NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_provenance.
- NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_assertion wasDerivedFrom befree-20140225 NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_provenance.
- NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_assertion wasGeneratedBy ECO_0000203 NP330341.RAG9Rc1Sy2DvLu3l7_rIPXgvE_REzuMWWmV6dH65vBQrE130_provenance.